Apriso Expands FlexNet for Life Sciences Solution with Containment Management

Drawing upon firm’s implementations across other industries, this capability is now available for Life Sciences manufacturers to better support their Quality, CAPA and Lean initiatives

(LONG BEACH, CA – June 25, 2008) – Apriso, a leading provider of adaptive software solutions for global manufacturing operations management, today announced expanded containment management capabilities with the general availability of FlexNet 9.4 SP1, which can help Life Sciences manufacturers seeking to better manage their Quality, CAPA and Lean initiatives.  Enhanced capabilities let manufacturers identify, isolate and take action on known or suspected quality defects within their raw materials, components and finished goods processes – within warehouse, production, quality and maintenance operations processes.

This FlexNet industry solution is currently enabling Life Sciences manufacturers, specifically in Medical Devices and Pharmaceuticals, to benefit from the industry’s only unified architecture for business processes.  By adding actionable capabilities to their CAPA and Quality Management Systems (QMS), these manufacturers can integrate quality execution with containment management to maintain brand equity while minimizing the alternative – a public product recall.

“Manufacturers have historically taken a very fragmented approach to the acquisition of quality management systems (QMS), with no overarching enterprise architecture in mind…These site-level deployments often lack integration with existing supplier management systems and MES investments.  They also don’t tie into similar systems across other manufacturing sites for networked event detection and alarming or consistent inspecting methodology,” said Simon Jacobson in the March 2008 AMR Research Report, “Laying the Framework for an Effective CAPA Strategy.” 

Apriso has a successful track record of integrating business processes spanning manufacturing operations, enterprise applications, such as ERP or PLM, and the equipment layer.  This tightly integrated operations infrastructure is highly conducive to Life Sciences manufacturer’s need for effective quality, CAPA and containment management capabilities.  Standardized business processes and compliance requirements can now be automated – across distributed operations – for the lowest total cost of ownership. 

“Apriso was the first to deploy native business process management (BPM) within our FlexNet Operations Execution System to integrate operations processes, enabling agility across manufacturing and the supply chain,” explains Rick Gallisa, industry director, Life Sciences at Apriso.  “The expanded capabilities of our Life Sciences solution simply builds upon the success already achieved in executing quality programs and Lean initiatives within this industry segment, especially for large scale, multi-site deployments incorporating Warehouse, Production, Labor and Maintenance operations.“

About Apriso
Apriso Corporation is a software company dedicated to providing competitive advantage for its customers.  It does so by enabling organizations to adapt quickly and easily to market changes and unexpected events.  Apriso’s FlexNet platform provides visibility, adaptability and real-time control of manufacturing operations across the enterprise and supply chain network.  This is accomplished by integrating planning, execution and control, increasing operational efficiency and eliminating errors in the production process. Apriso serves more than 170 customers in 41 countries across the Americas, Europe and Asia, powering more than 650 installations worldwide.  Its customers include General Motors, Lear, Honeywell, L'Oreal, Trixell, Lockheed Martin, Becton Dickinson, Saint-Gobain, Novelis and Essilor.  For more information, please go to www.apriso.com.

Apriso and FlexNet are registered trademarks of Apriso Corporation.  All other trademarks and registered trademarks are the property of their respective owners.